September 17, 2020
June 22, 2020
Biosimilars referencing Roche/Genentech’s portfolio of blockbuster oncology monoclonal antibodies—Avastin, Herceptin, and Rituxan—launched in the United States throughout the second half of…
June 22, 2020
April 24, 2020
March 23, 2020
December 31, 2019
November 18, 2019
November 6, 2019
October 9, 2019
August 30, 2019
August 16, 2019